ENGOT-gyn6 / NOGGO S30 / Expression XVIII
Fear of Cancer versus Fear of Crisis – International Patient Survey on the Influence of Crisis on Cancer Patients
NOGGO
ENGOT-OV62/ NOGGO OV 53/ N-Plus
A Phase III randomized, open label study of NiraParib maintenance after Carboplatin and Paclitaxel in optimaLly debUlked advanced HRDpositive high grade ovarian cancer patientS in first line therapy
Trial Number
NCT05460000 (ClinicalTrials.gov Identifier)Contact Person
Status
Disease Site
Lead Cooperative Group
Participating Groups
GCIG Number
ENGOT-EN16/ NOGGO S22/ Expression XI
IMPROVE - International Survey for Endometrial Cancer patients: perspective and expectation on therapy and quality of life
Trial Number
DRKS00025954Contact Person
Status
Disease Site
Lead Cooperative Group
Participating Groups
GCIG Number
ENGOT -gyn4/ NOGGO S20/ Expression IX
Long-term survival with gynecological cancer
Trial Number
DRKS00028769Contact Person
Status
Disease Site
Lead Cooperative Group
Participating Groups
GCIG Number
ENTO-OV40/ NOGGO S13/ Expression VI
Caroline meets HANNA – Holistic Analysis of long-term survivors with ovarian cancer